Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates
A first-in-human antibody–drug conjugate: Hope for patients with advanced solid tumours? | Immunopaedia
Clinical pharmacology of vc-MMAE antibody-drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies. - Abstract - Europe PMC
PEPTIDES & ANTIBODIES - Peptides in Antibody & Peptide Drug Conjugates
Development of MMAE-trastuzumab ADCs. MC-VC-PAB-MMAE was conjugated to... | Download Scientific Diagram
Anti-Monomethyl auristatin E (MMAE) monoclonal antibody(mAb) : Products and Application | GeneMedi
Advances in the Development of Dual-Drug Antibody Drug Conjugates » ADC Review
IJMS | Free Full-Text | Tumor Site-Specific Cleavage Improves the Antitumor Efficacy of Antibody–Drug Conjugates
Generation of the potent antibody-drug conjugate trastuzumab-(LAP·MMAE)... | Download Scientific Diagram
Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathy - ScienceDirect
Cancers | Free Full-Text | Antibody-Drug Conjugate Using Ionized Cys-Linker- MMAE as the Potent Payload Shows Optimal Therapeutic Safety
Monomethyl auristatin E (MMAE, vedotin), la charge utile de cytotoxiques brentuximab vedotin anticorps conjugué Photo Stock - Alamy
Anti-MMAE (Monomethyl auristatin E) Antibodies and MMAE Conjugates: For PK/PD Studies on MMAE-ADC - Creative Diagnostics
Payload of Antibody-drug Conjugates (ADCs) — MMAE and MMAF Brief Introduction – Creative Biolabs ADC Blog
Development of a Physiologically-Based Pharmacokinetic Model for Whole-Body Disposition of MMAE Containing Antibody-Drug Conjugate in Mice | Pharmaceutical Research
PDF] Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload | Semantic Scholar